Please login to the form below

Not currently logged in
Email:
Password:

Neon Therapeutics

This page shows the latest Neon Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Newly-listed BioNTech buys Neon to boost cell therapy assets

Newly-listed BioNTech buys Neon to boost cell therapy assets

German biotech has agreed to pay $67m in the deal. Just weeks after its $150m initial public offering, German biotech BioNTech has acquired troubled US counterpart Neon Therapeutics, adding to its ... BioNTech also gets rights to Neon’s

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    article – but, as recent experience with Incyte and Nektar Therapeutics has shown, not all new drugs and combinations will succeed. ... Candidates from Neon Therapeutics, Aduro and BioNTech have passed early-stage testing and are now being studied

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • US biotech Translate Bio appoints Daniella Beckman US biotech Translate Bio appoints Daniella Beckman

    Beckman has over 15 years’ of financial and operational experience and she currently provides consulting and interim chief financial officer services for early-stage biotech companies, including Tango Therapeutics and Neon ... Therapeutics. She said:

  • Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role

    Hugh O'Dowd, chief executive officer of Neon Therapeutics said the company was privileged to have Dr Gaynor join its team. ... His knowledge and leadership reinforces Neon Therapeutics' leadership in neoantigen-based immuno-oncology treatments.”.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...

Infographics